MD Anderson Study Links IL-18 Protein to Pancreatic Cancer Progression
Researchers have identified that the IL-18 protein helps pancreatic tumors evade the immune system, offering a potential new target for combination therapies.
🧠AI AnalysisPhoto: Medical Xpress
Key points
- IL-18 protein helps pancreatic tumors hide from immune cells by boosting CD47 signals.
- Reducing IL-18 levels in laboratory models slowed tumor growth and improved survival rates.
- Suppressing IL-18 may enhance the effectiveness of KRAS-targeted therapies and prevent drug resistance.
A research team at The University of Texas MD Anderson Cancer Center has identified a specific inflammatory protein, IL-18, as a key driver in the growth and immune evasion of pancreatic cancer. The study, led by Dr. Yang Chen and Dr. Xinlei Sun, suggests that this protein plays a central role in helping tumors remain undetected by the body's natural defenses, which contributes significantly to disease progression and lower survival rates.
The Mechanism of Immune Evasion
The findings, published in the journal Gastroenterology, demonstrate that IL-18 increases the levels of CD47, a protein known as a "don't eat me" signal. This signal effectively prevents macrophages—immune cells that typically destroy harmful cells—from identifying and attacking the tumor. In preclinical models, reducing the presence of IL-18 allowed macrophages to better recognize and eliminate cancer cells, leading to slower tumor growth and extended survival.
Synergy with Existing Treatments
The study also explored the interaction between IL-18 and KRAS inhibitors, a common class of drugs used to treat pancreatic cancer. Researchers observed that KRAS inhibition can actually cause IL-18 levels to rise, which may help the tumor survive the treatment. However, when the researchers combined KRAS inhibitors with the suppression of IL-18 in lab models, the anti-tumor response was significantly improved, suggesting a potential strategy for overcoming drug resistance.
While these results are promising, it is important to note that the research is currently in the preclinical stage. The study utilized genetically engineered laboratory models rather than human subjects, and further clinical trials are necessary to determine the safety and efficacy of IL-18-targeted therapies in patients. Scientists must still identify how to safely combine these treatments with existing medical protocols.
What to know: This research identifies a new biological pathway that could eventually lead to more effective combination treatments for pancreatic cancer.
Note: Readers should consult with a medical professional before making any decisions regarding cancer treatment or clinical trial participation.
Source Medical Xpress — medicalxpress.com/news/2026-11-key-immune-driver-pancreatic-cancer.html ↗
Read next
🧠Mind & Mental HealthAddressing Body Image and the Reality of Gluteal Anatomy
A personal reflection on the social and psychological impact of body shape, specifically regarding the gluteal region, and the limitations of consumer solutions for perce…
❤️Conditions & CareMigraine and Smoking Linked to Increased Early Stroke Risk in Women
A large-scale study suggests that people who have given birth and experience migraines while also smoking face a significantly higher risk of stroke before age 60.
🔬ResearchCBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities
A double-blind clinical trial published in JAMA Pediatrics indicates that CBD oil provides no significant behavioral improvement for children and teenagers with intellect…
🏃FitnessExpert Advice on Hydration Gear Sparks Debate Among Recreational Runners
Olympic medalist Josh Kerr recently suggested that runners may not require hydration packs for distances under 12 miles, igniting a broader conversation about gear necess…
🏃FitnessA Structured Approach to Beginning a Strength and Cardio Routine
A new four-week training program offers beginners a guided path to incorporating strength training and cardiovascular exercise into their daily lives.
🧠Mind & Mental HealthThe Role of Daily Mobility Training in Managing Sedentary Tension
A two-week personal trial suggests that incorporating short, daily mobility exercises may help alleviate stiffness associated with sedentary desk work. Experts note that …